Catalyst Wire Dossier Catalyst Wire Dossier

Sublingual House Dust Mite Tablet (100IR/300IR/500IR)

house dust mite sublingual immunotherapy tablet · Stallergenes Greer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sublingual House Dust Mite Tablet (100IR/300IR/500IR), covering 2025-02-04 to 2025-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model [Phase 2]

See pricing